Wall Street Breakfast Podcast: Copper Retreats, Crude Oil Gains

President Trump escalated trade tensions by threatening a 50% tariff on copper and up to 200% on pharmaceuticals, causing copper to slump ~2.8% and prompting U.S. manufacturing expansion by some pharma firms. In other market news, gold and silver fell on rising yields and a stronger dollar, while Brent crude rose on supply concerns. Separately, Wedbush's Dan Ives urged Tesla's board to curb Elon Musk's political activities, citing their negative impact on TSLA shares, a sentiment echoed by William Blair. Additionally, the Dallas Fed warned that stricter immigration policies under Trump could reduce U.S. GDP growth by approximately 0.8 percentage points.

Analysis

Escalating trade policy risk is creating significant market divergence, headlined by President Trump's proposed tariffs of 50% on copper and up to 200% on pharmaceuticals. The copper tariff threat, potentially effective by August 1, triggered an immediate ~2.8% slump in the metal's price after it had reached record highs. In contrast, the pharmaceutical tariffs come with a 1 to 1.5-year grace period, and major firms including Merck (MRK), Johnson & Johnson (JNJ), and Eli Lilly (LLY) are already mitigating this future risk by expanding their U.S. manufacturing footprint. Adding to macroeconomic concerns, a Dallas Fed study warns that restrictive immigration policies could reduce U.S. GDP growth by 0.8 percentage points. In commodity markets, this political risk is contrasted by fundamental drivers, with Brent crude rising above $70.30 per barrel on supply concerns and downward revisions to U.S. production forecasts. Meanwhile, precious metals are pressured by a stronger dollar and rising yields ahead of key FOMC minutes. On the corporate governance front, Tesla (TSLA) faces mounting pressure as prominent bull Dan Ives of Wedbush and analysts at William Blair call for board intervention to curb CEO Elon Musk's political activities, which were cited as a key factor in the stock's recent 7% single-day decline and are viewed as a distraction from critical growth initiatives like the robotaxi rollout.

Key Decisions for Investors

• Investors in Tesla (TSLA) should closely monitor board actions regarding CEO oversight, as the market is clearly penalizing the stock for governance concerns and perceived distractions from core business execution.
• Consider re-evaluating pharmaceutical sector exposure, favoring companies like MRK, JNJ, and LLY that are proactively expanding their U.S. manufacturing to insulate themselves from the severe long-term risk of proposed 200% import tariffs.
• Approach the commodities sector with a nuanced strategy, recognizing the divergence between politically-driven weakness in industrial metals like copper and fundamentally-supported strength in energy markets like crude oil.
• Maintain a cautious outlook on broad market indices due to the confluence of escalating trade tariff risks, potential GDP headwinds from immigration policy, and uncertainty over the Federal Reserve's rate path.